Characterization of Trex1 induction by IFN-γ in murine macrophages

Journal of Immunology

Volumn 186, Issue 4, 2011, Pages 2299-2308

  Serra, Maria ^a   Forcales, Sonia Vanina ^a   Pereira Lopes, Selma ^a   Lloberas, Jorge ^a   Celada, Antonio ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

3' REPAIR EXONUCLEASE; ADAPTOR PROTEIN; ADAPTOR PROTEIN COMPLEX 1 BOX; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EXONUCLEASE; GAMMA INTERFERON; MESSENGER RNA; PROTEIN C JUN; SINGLE STRANDED DNA; STAT1 PROTEIN; TRANSCRIPTION FACTOR JUNB; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE CONTROL; GENE INDUCTION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HALF LIFE TIME; IMMUNOPRECIPITATION; INTRON; KNOCKOUT MOUSE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; TRANSCRIPTION INITIATION SITE; TRANSIENT TRANSFECTION;

ADAPTOR PROTEIN COMPLEX 1; ANIMALS; CELL LINE; CELLS, CULTURED; EXODEOXYRIBONUCLEASES; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA; MACROPHAGE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PHOSPHOPROTEINS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION INITIATION SITE; UP-REGULATION;

EID: 79951836166     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002364     Document Type: Article

References (45)

1. Perrino, F. W., H. Miller, and K. A. Ealey. 1994. Identification of a 3′→5′- exonuclease that removes cytosine arabinoside monophosphate from 3′ termini of DNA. J. Biol. Chem. 269: 16357-16363.
2. Rigby, R. E., A. Leitch, and A. P. Jackson. 2008. Nucleic acid-mediated inflammatory diseases. Bioessays 30: 833-842.
3. Morita, M., G. Stamp, P. Robins, A. Dulic, I. Rosewell, G. Hrivnak, G. Daly, T. Lindahl, and D. E. Barnes. 2004. Gene-targeted mice lacking the Trex1 (DNase III) 3′→5′ DNA exonuclease develop inflammatory myocarditis. Mol. Cell. Biol. 24: 6719-6727.
4. Crow, Y. J., and J. Rehwinkel. 2009. Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. Hum. Mol. Genet. 18(R2): R130-R136.
5. Yang, Y. G., T. Lindahl, and D. E. Barnes. 2007. Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell 131: 873-886.
6. Stetson, D. B., J. S. Ko, T. Heidmann, and R. Medzhitov. 2008. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134: 587-598.
7. Yan, N., A. D. Regalado-Magdos, B. Stiggelbout, M. A. Lee-Kirsch, and J. Lieberman. 2010. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat. Immunol. 11: 1005-1013.
8. Celada, A., and C. Nathan. 1994. Macrophage activation revisited. Immunol. Today 15: 100-102. (Pubitemid 24076324)
9. Boehm, U., T. Klamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15: 749-795.
10. Bach, E. A., M. Aguet, and R. D. Schreiber. 1997. The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15: 563-591.
11. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8: 958-969.
12. Darnell, J. E., Jr. 1998. Studies of IFN-induced transcriptional activation uncover the Jak-Stat pathway. J. Interferon Cytokine Res. 18: 549-554.
13. Chatterjee-Kishore, M., K. L.Wright, J. P. Ting, and G. R. Stark. 2000. How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene. EMBO J. 19: 4111-4122.
14. Brucet, M., J. Querol-Audí, M. Serra, X. Ramirez-Espain, K. Bertlik, L. Ruiz, J. Lloberas, M. J. Macias, I. Fita, and A. Celada. 2007. Structure of the dimeric exonuclease TREX1 in complex with DNA displays a proline-rich binding site for WW Domains. J. Biol. Chem. 282: 14547-14557.
15. Brucet, M., J. Querol-Audí, K. Bertlik, J. Lloberas, I. Fita, and A. Celada. 2008. Structural and biochemical studies of TREX1 inhibition by metals. Identification of a new active histidine conserved in DEDDh exonucleases. Protein Sci. 17: 2059-2069.
16. Celada, A., P. W. Gray, E. Rinderknecht, and R. D. Schreiber. 1984. Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity. J. Exp. Med. 160: 55-74.
17. Celada, A., R. Allen, I. Esparza, P. W. Gray, and R. D. Schreiber. 1985. Demonstration and partial characterization of the interferon-gamma receptor on human mononuclear phagocytes. J. Clin. Invest. 76: 2196-2205.
18. Casals, C., M. Barrachina, M. Serra, J. Lloberas, and A. Celada. 2007. Lipopolysaccharide up-regulates MHC class II expression on dendritic cells through an AP-1 enhancer without affecting the levels of CIITA. J. Immunol. 178: 6307-6315. (Pubitemid 46717414)
19. Fenton, M. J., and D. T. Golenbock. 1998. LPS-binding proteins and receptors. J. Leukoc. Biol. 64: 25-32.
20. Xaus, J., M. Mirabet, J. Lloberas, C. Soler, C. Lluis, R. Franco, and A. Celada. 1999. IFN-gamma up-regulates the A2B adenosine receptor expression in macrophages: a mechanism of macrophage deactivation. J. Immunol. 162: 3607-3614. (Pubitemid 29313615)
21. Celada, A., M. Shiga, M. Imagawa, J. Kop, and R. A. Maki. 1988. Identification of a nuclear factor that binds to a conserved sequence of the I-A beta gene. J. Immunol. 140: 3995-4002.
22. Sebastián, C., M. Serra, A. Yeramian, N. Serrat, J. Lloberas, and A. Celada. 2008. Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells. J. Immunol. 180: 5898-5906.
23. Celada, A., and R. Maki. 1989. Evidence for multiple major histocompatibility class II X-box binding proteins. Mol. Cell. Biol. 9: 5219-5222.
24. Valledor, A. F., E. Sánchez-Tilló, L. Arpa, J. M. Park, C. Caelles, J. Lloberas, and A. Celada. 2008. Selective roles of MAPKs during the macrophage response to IFN-gamma. J. Immunol. 180: 4523-4529.
25. Eferl, R., and E. F. Wagner. 2003. AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3: 859-868.
26. van Dam, H., and M. Castellazzi. 2001. Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis. Oncogene 20: 2453-2464. (Pubitemid 32531302)
27. Tamura, T., and K. Mikoshiba. 1991. Role of a GC-rich motif in transcription regulation of the adenovirus type 2 IVa2 promoter which lacks typical TATA-box element. FEBS Lett. 282: 87-90.
28. Boisclair, Y. R., A. L. Brown, S. Casola, and M. M. Rechler. 1993. Three clustered Sp1 sites are required for efficient transcription of the TATA-less promoter of the gene for insulin-like growth factor-binding protein-2 from the rat. J. Biol. Chem. 268: 24892-24901.
29. Lu, J., W. Lee, C. Jiang, and E. B. Keller. 1994. Start site selection by Sp1 in the TATA-less human Ha-ras promoter. J. Biol. Chem. 269: 5391-5402.
30. Zahedi, K., A. E. Prada, and A. E. Davis, III. 1994. Transcriptional regulation of the C1 inhibitor gene by gamma-interferon. J. Biol. Chem. 269: 9669-9674.
31. Grötzinger, T., K. Jensen, and H. Will. 1996. The interferon (IFN)-stimulated gene Sp100 promoter contains an IFN-gamma activation site and an imperfect IFN-stimulated response element which mediate type I IFN inducibility. J. Biol. Chem. 271: 25253-25260.
32. Kuhen, K. L., J. W. Vessey, and C. E. Samuel. 1998. Mechanism of interferon action: identification of essential positions within the novel 15-base-pair KCS element required for transcriptional activation of the RNA-dependent protein kinase pkr gene. J. Virol. 72: 9934-9939.
33. George, C. X., and C. E. Samuel. 1999. Characterization of the 5′-flanking region of the human RNA-specific adenosine deaminase ADAR1 gene and identification of an interferon-inducible ADAR1 promoter. Gene 229: 203-213.
34. Khabar, K. S. 2007. Rapid transit in the immune cells: the role of mRNA turnover regulation. J. Leukoc. Biol. 81: 1335-1344.
35. Chowdhury, D., P. J. Beresford, P. Zhu, D. Zhang, J. S. Sung, B. Demple, F. W. Perrino, and J. Lieberman. 2006. The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme A-mediated cell death. Mol. Cell 23: 133-142. (Pubitemid 43963449)
36. Richards, A., A. M. van den Maagdenberg, J. C. Jen, D. Kavanagh, P. Bertram, D. Spitzer, M. K. Liszewski, M. L. Barilla-Labarca, G. M. Terwindt, Y. Kasai, et al. 2007. C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat. Genet. 39: 1068-1070.
37. Platanias, L. C. 2005. Mechanisms of type-I- and type-II-interferon- mediated signalling. Nat. Rev. Immunol. 5: 375-386.
38. Shaulian, E., and M. Karin. 2002. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4: E131-E136.
39. Hayakawa, J., S. Mittal, Y. Wang, K. S. Korkmaz, E. Adamson, C. English, M. Ohmichi, M. Omichi, M. McClelland, and D. Mercola. 2004. Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress. Mol. Cell 16: 521-535. (Pubitemid 39531876)
40. Shaulian, E., and M. Karin. 2001. AP-1 in cell proliferation and survival. Oncogene 20: 2390-2400. (Pubitemid 32531297)
41. Christmann, M., M. T. Tomicic, D. Aasland, N. Berdelle, and B. Kaina. 2010. Three prime exonuclease I (TREX1) is Fos/AP-1 regulated by genotoxic stress and protects against ultraviolet light and benzo(a)pyrene-induced DNA damage. Nucleic Acids Res. 38: 6418-6432.
42. Gongora, C., G. Degols, L. Espert, T. D. Hua, and N. Mechti. 2000. A unique ISRE, in the TATA-less human Isg20 promoter, confers IRF-1-mediated responsiveness to both interferon type I and type II. Nucleic Acids Res. 28: 2333-2341. (Pubitemid 30349038)
43. Degols, G., P. Eldin, and N. Mechti. 2007. ISG20, an actor of the innate immune response. Biochimie 89: 831-835. (Pubitemid 47001639)
44. Crow, Y. J., B. E. Hayward, R. Parmar, P. Robins, A. Leitch, M. Ali, D. N. Black, H. van Bokhoven, H. G. Brunner, B. C. Hamel, et al. 2006. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus. Nat. Genet. 38: 917-920.
45. Lee-Kirsch, M. A., M. Gong, D. Chowdhury, L. Senenko, K. Engel, Y. A. Lee, U. de Silva, S. L. Bailey, T. Witte, T. J. Vyse, et al. 2007. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat. Genet. 39: 1065-1067.